EARS
by Anonymous Questions | January 12, 2016 9:01 pm
All of the major financial advisors were hyping some big announcement to occur right after the first of the year that was going to cause EARS stock price to rocket higher.
Given what’s actually happened, would you classify that as a classical ’pump and dump[1]’ scheme on a very broad basis?
Endnotes:
- pump and dump: https://www.stockgumshoe.com/tag/pump-and-dump/
Source URL: https://www.stockgumshoe.com/2016/01/microblog-ears/
Did they say what the event would be? I don’t remember anything other than finding enough clues to ID the stock, but newsletters often exaggerate the potential catalysts in their ads — they generally don’t care if you buy the stock, they don’t profit from that, they profit from subscriptions… And people won’t buy subscriptions as merrily unless they can create an urgent reason for you to subscribe RIGHT NOW.
Major financial experts record of success may be checked for free or for relatively small cost here: https://www.tipranks.com/stocks/ears Best2All-Ben
Travis: “And people won’t buy subscriptions as merrily unless they can create an urgent reason for you to subscribe RIGHT NOW.”….exactly, which is why (days ago) I questioned whether anyone heard of disappointing news or a lack of “touted” anticipated news.
@ Anonymous Questions, how do you define ” major financial advisors”? The only teaser article I was aware of, came from Money Map Press. They did not suggest a time frame. Were there others? What had you heard?
From the 3rd quarter report:
“The Company expects to have first top-line Phase 3 clinical data for AM-101 in the second quarter of 2016”. The drug is meant to reduce the symptoms of tinnitus.
Ears now has 2 top-line Phase 3 tests coming. First is due on 8/31 and the second in the 4th quarter. This is for their drug AM-101. The Phase 3 testing results for their other drug AM-111 is due 4th quarter 17. There is no competition for treatment of inner ear tinnitus.
This is a true statement this time around, and I know it sounds shady, but it won’t happen over night without sponsors to pump out the financial investments in the only two Doctors who possess the power to light the stock market back up by providing their internal medicine campaign together.
small caps have been getting slaughtered. Nothing new.
Just bidness as usual, only the mkt. shortened the length of the pump. Look at the dates in the news/pr section in relation to the chart in Dec,.
Stock Quote EARS Auris Medical Holding AG
http://finviz.com/quote.ashx?t=ears
ads stopped and were pulled on 52 week high. They really did a great job with this one, especially after MNGA. SUNE and NVDA sucked but those were to big.
When the stock settles back at a lower level, maybe now after all the carnage in the sector, is it worth a small punt given it operates in an area of unmet medical need and has some research affiliations with King’s College London, for example?
Relevant also to consider who else may or may not be involved in this area of healthcare, but personally have no knowledge of that.
Recent updates on this have been posted on Dr KSS threads.
Has anyone looked at the latest news/claims from this company lately?